{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:35:49Z","timestamp":1791894949865,"version":"4.3.4"},"publisher-location":"Cham","reference-count":58,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031571640","type":"print"},{"value":"9783031571657","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-57165-7_9","type":"book-chapter","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T07:02:03Z","timestamp":1716793323000},"page":"139-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Biology of Variola Virus"],"prefix":"10.1007","author":[{"given":"Poornima","family":"Gopi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanan Valiya","family":"Veettil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"issue":"12\u201313","key":"9_CR1","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.micinf.2010.07.007","volume":"12","author":"D Alzhanova","year":"2010","unstructured":"Alzhanova D, Fr\u00fch K (2010) Modulation of the host immune response by cowpox virus. Microbes Infect 12(12\u201313):900\u2013909","journal-title":"Microbes Infect"},{"issue":"25","key":"9_CR2","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1016\/j.vaccine.2005.01.079","volume":"23","author":"AW Artenstein","year":"2005","unstructured":"Artenstein AW, Johnson C, Marbury TC, Morrison D, Blum PS, Kemp T et al (2005) A novel, cell culture-derived smallpox vaccine in vaccinia-na\u00efve adults. Vaccine 23(25):3301\u20133309","journal-title":"Vaccine"},{"issue":"6","key":"9_CR3","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1128\/jvi.67.6.3515-3527.1993","volume":"67","author":"CJ Baldick Jr","year":"1993","unstructured":"Baldick CJ Jr, Moss B (1993) Characterization and temporal regulation of mRNAs encoded by vaccinia virus intermediate-stage genes. J Virol 67(6):3515\u20133527","journal-title":"J Virol"},{"issue":"2","key":"9_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0092-8674(82)90349-X","volume":"28","author":"BM Baroudy","year":"1982","unstructured":"Baroudy BM, Venkatesan S, Moss B (1982) Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain. Cell 28(2):315\u2013324","journal-title":"Cell"},{"issue":"1","key":"9_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1086\/315190","volume":"181","author":"M Bray","year":"2000","unstructured":"Bray M, Martinez M, Smee DF, Kefauver D, Thompson E, Huggins JW (2000) Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge. J Infect Dis 181(1):10\u201319","journal-title":"J Infect Dis"},{"issue":"17","key":"9_CR6","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1056\/NEJMra020025","volume":"346","author":"JG Breman","year":"2002","unstructured":"Breman JG, Henderson DA (2002) Diagnosis and management of smallpox. N Engl J Med 346(17):1300\u20131308","journal-title":"N Engl J Med"},{"issue":"Pt 9","key":"9_CR7","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1099\/vir.0.18942-0","volume":"84","author":"SS Broyles","year":"2003","unstructured":"Broyles SS (2003) Vaccinia virus transcription. J Gen Virol 84(Pt 9):2293\u20132303","journal-title":"J Gen Virol"},{"issue":"40","key":"9_CR8","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","volume":"28","author":"GW Buchman","year":"2010","unstructured":"Buchman GW, Cohen ME, Xiao Y, Richardson-Harman N, Silvera P, DeTolla LJ et al (2010) A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge. Vaccine 28(40):6627\u20136636","journal-title":"Vaccine"},{"issue":"1","key":"9_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/mr.55.1.80-122.1991","volume":"55","author":"RM Buller","year":"1991","unstructured":"Buller RM, Palumbo GJ (1991) Poxvirus pathogenesis. Microbiol Rev 55(1):80\u2013122","journal-title":"Microbiol Rev"},{"issue":"21","key":"9_CR10","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","volume":"294","author":"CG Casey","year":"2005","unstructured":"Casey CG, Iskander JK, Roper MH, Mast EE, Wen XJ, Torok TJ et al (2005) Adverse events associated with smallpox vaccination in the United States, January\u2013October 2003. JAMA 294(21):2734\u20132743","journal-title":"JAMA"},{"key":"9_CR11","unstructured":"Committee on the Assessment of Future Scientific Needs for Variola Virus (1999) Smallpox and its control. In: Briere R (ed) Assessment of future scientific needs for live variola virus. National Academies Press (US), Washington, DC, pp 17\u201346"},{"issue":"Pt 8","key":"9_CR12","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1099\/vir.0.010553-0","volume":"90","author":"IK Damon","year":"2009","unstructured":"Damon IK, Davidson WB, Hughes CM, Olson VA, Smith SK, Holman RC et al (2009) Evaluation of smallpox vaccines using variola neutralization. J Gen Virol 90(Pt 8):1962\u20131966","journal-title":"J Gen Virol"},{"issue":"47","key":"9_CR13","doi-asserted-by":"publisher","first-page":"18724","DOI":"10.1073\/pnas.0709276104","volume":"104","author":"FS De Silva","year":"2007","unstructured":"De Silva FS, Lewis W, Berglund P, Koonin EV, Moss B (2007) Poxvirus DNA primase. Proc Natl Acad Sci USA 104(47):18724\u201318729","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1067\/mjd.2001.109302","volume":"44","author":"DG Diven","year":"2001","unstructured":"Diven DG (2001) An overview of poxviruses. J Am Acad Dermatol 44(1):1\u201316","journal-title":"J Am Acad Dermatol"},{"key":"9_CR16","unstructured":"Fields BN (2007) Fields\u2019 virology. Lippincott Williams & Wilkins"},{"issue":"11","key":"9_CR17","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.bbapap.2006.09.006","volume":"1764","author":"IP Gileva","year":"2006","unstructured":"Gileva IP, Nepomnyashchikh TS, Antonets DV, Lebedev LR, Kochneva GV, Grazhdantseva AV et al (2006) Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different. Biochim Biophys Acta 1764(11):1710\u20131718","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"9_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042353","volume":"7","author":"JW Golden","year":"2012","unstructured":"Golden JW, Josleyn M, Mucker EM, Hung CF, Loudon PT, Wu TC et al (2012) Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates. PLoS ONE 7(7):e42353","journal-title":"PLoS ONE"},{"issue":"4","key":"9_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/13543784.17.4.555","volume":"17","author":"RN Greenberg","year":"2008","unstructured":"Greenberg RN, Kennedy JS (2008) ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine. Expert Opin Investig Drugs 17(4):555\u2013564","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"9_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138348","volume":"10","author":"RN Greenberg","year":"2015","unstructured":"Greenberg RN, Hurley MY, Dinh DV, Mraz S, Vera JG, von Bredow D et al (2015) A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18\u201340 year old subjects with diagnosed atopic dermatitis. PLoS ONE 10(10):e0138348","journal-title":"PLoS ONE"},{"issue":"22","key":"9_CR21","doi-asserted-by":"publisher","first-page":"11034","DOI":"10.1128\/JVI.75.22.11034-11055.2001","volume":"75","author":"G Griffiths","year":"2001","unstructured":"Griffiths G, Wepf R, Wendt T, Locker JK, Cyrklaff M, Roos N (2001) Structure and assembly of intracellular mature vaccinia virus: isolated-particle analysis. J Virol 75(22):11034\u201311055","journal-title":"J Virol"},{"issue":"4","key":"9_CR22","first-page":"479","volume":"59","author":"GJ Harper","year":"1961","unstructured":"Harper GJ (1961) Airborne micro-organisms: survival tests with four viruses. J Hyg (Lond) 59(4):479\u2013486","journal-title":"J Hyg (Lond)"},{"issue":"31","key":"9_CR23","doi-asserted-by":"publisher","first-page":"11178","DOI":"10.1073\/pnas.0403600101","volume":"101","author":"SC Harrison","year":"2004","unstructured":"Harrison SC, Alberts B, Ehrenfeld E, Enquist L, Fineberg H, McKnight SL et al (2004) Discovery of antivirals against smallpox. Proc Natl Acad Sci USA 101(31):11178\u201311192","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9_CR24","first-page":"279","volume":"54","author":"AC Hekker","year":"1976","unstructured":"Hekker AC, Bos JM, Rai NK, Keja J, Cuboni G, Emmet B et al (1976) Large-scale use of freeze-dried smallpox vaccine prepared in primary cultures of rabbit kidney cells. Bull World Health Organ 54(3):279\u2013284","journal-title":"Bull World Health Organ"},{"issue":"3","key":"9_CR25","first-page":"107","volume":"85","author":"DA Henderson","year":"2002","unstructured":"Henderson DA (2002) Smallpox: clinical and epidemiologic features. Med Health R I 85(3):107\u2013108","journal-title":"Med Health R I"},{"key":"9_CR26","doi-asserted-by":"crossref","unstructured":"Henderson DA (2011) The eradication of smallpox\u2014an overview of the past, present, and future. Vaccine 29(Suppl 4):D7\u2013D9","DOI":"10.1016\/j.vaccine.2011.06.080"},{"issue":"4","key":"9_CR27","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","volume":"177","author":"JM Heraud","year":"2006","unstructured":"Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS et al (2006) Subunit recombinant vaccine protects against monkeypox. J Immunol 177(4):2552\u20132564","journal-title":"J Immunol"},{"issue":"6","key":"9_CR28","first-page":"710","volume":"54","author":"F Huq","year":"1976","unstructured":"Huq F (1976) Effect of temperature and relative humidity on variola virus in crusts. Bull World Health Organ 54(6):710\u2013712","journal-title":"Bull World Health Organ"},{"issue":"36","key":"9_CR29","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1016\/j.vaccine.2010.06.063","volume":"28","author":"HC Jang","year":"2010","unstructured":"Jang HC, Kim CJ, Kim KH, Lee KH, Byun YH, Seong BL et al (2010) A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers. Vaccine 28(36):5845\u20135849","journal-title":"Vaccine"},{"issue":"1","key":"9_CR30","first-page":"34","volume":"17","author":"S Kato","year":"1959","unstructured":"Kato S, Cutting W (1959) A study of the inclusion bodies of rabbit myxoma and fibroma virus and a consideration of the relationship between all pox virus inclusion bodies. Stanford Med Bull 17(1):34\u201345","journal-title":"Stanford Med Bull"},{"key":"9_CR31","doi-asserted-by":"crossref","unstructured":"Lalezari JP, Stagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV et al (1997) Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med 126(4):257\u2013263","DOI":"10.7326\/0003-4819-126-4-199702150-00001"},{"issue":"1","key":"9_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.antiviral.2010.11.006","volume":"89","author":"S Langhammer","year":"2011","unstructured":"Langhammer S, Koban R, Yue C, Ellerbrok H (2011) Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa\u2122). Antiviral Res 89(1):64\u201370","journal-title":"Antiviral Res"},{"issue":"3","key":"9_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrmicro1099","volume":"3","author":"G McFadden","year":"2005","unstructured":"McFadden G (2005) Poxvirus tropism. Nat Rev Microbiol 3(3):201\u2013213","journal-title":"Nat Rev Microbiol"},{"issue":"5875","key":"9_CR34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.1155164","volume":"320","author":"J Mercer","year":"2008","unstructured":"Mercer J, Helenius A (2008) Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320(5875):531\u2013535","journal-title":"Science"},{"issue":"20","key":"9_CR35","doi-asserted-by":"publisher","first-page":"9346","DOI":"10.1073\/pnas.1004618107","volume":"107","author":"J Mercer","year":"2010","unstructured":"Mercer J, Knebel S, Schmidt FI, Crouse J, Burkard C, Helenius A (2010) Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry. Proc Natl Acad Sci USA 107(20):9346\u20139351","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR36","first-page":"119","volume":"269","author":"H Meyer","year":"2004","unstructured":"Meyer H, Damon IK, Esposito JJ (2004) Orthopoxvirus diagnostics. Methods Mol Biol 269:119\u2013134","journal-title":"Methods Mol Biol"},{"key":"9_CR37","doi-asserted-by":"crossref","unstructured":"Modrow S, Falke D, Truyen U, Sch\u00e4tzl H (eds) (2013) Molecular virology: springer reference, pp 829\u2013856","DOI":"10.1007\/978-3-642-20718-1"},{"issue":"9508","key":"9_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0140-6736(06)68143-9","volume":"367","author":"ZS Moore","year":"2006","unstructured":"Moore ZS, Seward JF, Lane JM (2006) Smallpox. Lancet 367(9508):425\u2013435","journal-title":"Lancet"},{"key":"9_CR39","doi-asserted-by":"crossref","unstructured":"Moss B (2013) Poxvirus DNA replication. Cold Spring Harb Perspect Biol 5(9)","DOI":"10.1101\/cshperspect.a010199"},{"issue":"1","key":"9_CR40","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.icb.7100118","volume":"86","author":"V Panchanathan","year":"2008","unstructured":"Panchanathan V, Chaudhri G, Karupiah G (2008) Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol Cell Biol 86(1):80\u201386","journal-title":"Immunol Cell Biol"},{"key":"9_CR41","doi-asserted-by":"crossref","unstructured":"Petersen BW, Karem KL, Damon IK (2014) Orthopoxviruses: variola, vaccinia, cowpox, and monkeypox. In: Kaslow RA, Stanberry LR, Duc JWL (eds) Viral infections of humans, epidemiology and control, 4 edn. Springer Science + Business media, New York, pp 501\u2013518","DOI":"10.1007\/978-1-4899-7448-8_21"},{"issue":"1","key":"9_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.antiviral.2006.02.010","volume":"71","author":"DC Quenelle","year":"2006","unstructured":"Quenelle DC, Keith KA, Kern ER (2006) In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Antiviral Res 71(1):24\u201330","journal-title":"Antiviral Res"},{"issue":"7","key":"9_CR43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nm1265","volume":"11","author":"PM Reeves","year":"2005","unstructured":"Reeves PM, Bommarius B, Lebeis S, McNulty S, Christensen J, Swimm A et al (2005) Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat Med 11(7):731\u2013739","journal-title":"Nat Med"},{"issue":"1","key":"9_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/JVI.01814-10","volume":"85","author":"PM Reeves","year":"2011","unstructured":"Reeves PM, Smith SK, Olson VA, Thorne SH, Bornmann W, Damon IK et al (2011) Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases. J Virol 85(1):21\u201331","journal-title":"J Virol"},{"issue":"1","key":"9_CR45","first-page":"21","volume":"18","author":"S Riedel","year":"2005","unstructured":"Riedel S (2005) Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent). 18(1):21\u201325","journal-title":"Proc (Bayl Univ Med Cent)."},{"issue":"10","key":"9_CR46","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.tim.2008.07.009","volume":"16","author":"KL Roberts","year":"2008","unstructured":"Roberts KL, Smith GL (2008) Vaccinia virus morphogenesis and dissemination. Trends Microbiol 16(10):472\u2013479","journal-title":"Trends Microbiol"},{"issue":"7","key":"9_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002628","volume":"3","author":"KH Rubins","year":"2008","unstructured":"Rubins KH, Hensley LE, Bell GW, Wang C, Lefkowitz EJ, Brown PO et al (2008) Comparative analysis of viral gene expression programs during poxvirus infection: a transcriptional map of the vaccinia and monkeypox genomes. PLoS ONE 3(7):e2628","journal-title":"PLoS ONE"},{"issue":"4","key":"9_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000866","volume":"6","author":"KJ Sandgren","year":"2010","unstructured":"Sandgren KJ, Wilkinson J, Miranda-Saksena M, McInerney GM, Byth-Wilson K, Robinson PJ et al (2010) A differential role for macropinocytosis in mediating entry of the two forms of vaccinia virus into dendritic cells. PLoS Pathog 6(4):e1000866","journal-title":"PLoS Pathog"},{"issue":"1","key":"9_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.coviro.2011.11.007","volume":"2","author":"FI Schmidt","year":"2012","unstructured":"Schmidt FI, Bleck CK, Mercer J (2012) Poxvirus host cell entry. Curr Opin Virol 2(1):20\u201327","journal-title":"Curr Opin Virol"},{"issue":"35","key":"9_CR50","doi-asserted-by":"publisher","first-page":"10908","DOI":"10.1073\/pnas.1514809112","volume":"112","author":"TG Senkevich","year":"2015","unstructured":"Senkevich TG, Bruno D, Martens C, Porcella SF, Wolf YI, Moss B (2015) Mapping vaccinia virus DNA replication origins at nucleotide level by deep sequencing. Proc Natl Acad Sci USA 112(35):10908\u201310913","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/A:1022324511384","volume":"37","author":"SN Shchelkunov","year":"2003","unstructured":"Shchelkunov SN (2003) Immunomodulatory proteins of orthopoxviruses. Mol Biol (Mosk) 37(1):41\u201353","journal-title":"Mol Biol (Mosk)"},{"key":"9_CR52","unstructured":"Smallpox Disease and Its Clinical Management. From the training course titled \u201cSmallpox: disease, prevention, and intervention\u201d. Available at www.bt.cdc.gov\/agent\/smallpox\/training\/overview"},{"issue":"1","key":"9_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/095632020101200105","volume":"12","author":"DF Smee","year":"2001","unstructured":"Smee DF, Bailey KW, Sidwell RW (2001) Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir. Antivir Chem Chemother 12(1):71\u201376","journal-title":"Antivir Chem Chemother"},{"issue":"1","key":"9_CR54","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/0042-6822(92)90752-B","volume":"188","author":"J Tartaglia","year":"1992","unstructured":"Tartaglia J, Perkus ME, Taylor J, Norton EK, Audonnet JC, Cox WI et al (1992) NYVAC: a highly attenuated strain of vaccinia virus. Virology 188(1):217\u2013232","journal-title":"Virology"},{"issue":"4","key":"9_CR55","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1128\/MMBR.00026-09","volume":"73","author":"K Van Vliet","year":"2009","unstructured":"Van Vliet K, Mohamed MR, Zhang L, Villa NY, Werden SJ, Liu J et al (2009) Poxvirus proteomics and virus-host protein interactions. Microbiol Mol Biol Rev 73(4):730\u2013749","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"9_CR56","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/003693309704200407","volume":"42","author":"NJ Willis","year":"1997","unstructured":"Willis NJ (1997) Edward Jenner and the eradication of smallpox. Scott Med J 42(4):118\u2013121","journal-title":"Scott Med J"},{"issue":"6","key":"9_CR57","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.vaccine.2006.09.046","volume":"25","author":"I Wiser","year":"2007","unstructured":"Wiser I, Balicer RD, Cohen D (2007) An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies. Vaccine 25(6):976\u2013984","journal-title":"Vaccine"},{"issue":"20","key":"9_CR58","doi-asserted-by":"publisher","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","volume":"79","author":"G Yang","year":"2005","unstructured":"Yang G, Pevear DC, Davies MH, Collett MS, Bailey T, Rippen S et al (2005a) An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. J Virol 79(20):13139\u201313149","journal-title":"J Virol"},{"issue":"2","key":"9_CR59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1172\/JCI200523220","volume":"115","author":"H Yang","year":"2005","unstructured":"Yang H, Kim SK, Kim M, Reche PA, Morehead TJ, Damon IK et al (2005b) Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction. J Clin Invest 115(2):379\u2013387","journal-title":"J Clin Invest"}],"container-title":["Advances in Experimental Medicine and Biology","Poxviruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-57165-7_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T07:05:10Z","timestamp":1716793510000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-57165-7_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031571640","9783031571657"],"references-count":58,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-57165-7_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"28 May 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}